AngioDynamics to Appeal Patent Infringement Verdict QUEENSBURY, N.Y.--(BUSINESS WIRE)--March 28, 2007--AngioDynamics, Inc. (NASDAQ:ANGO) announced it will act to set aside, and if necessary, will appeal the jury verdict returned in favor of Diomed, Inc.

AngioDynamics Reports Strong Fiscal Third Quarter Results AngioDynamics Reports Strong Fiscal Third Quarter Results Net Sales Set New Quarterly Record Strong Free Cash Flow Generation Continues RITA Medical Acquisition Integration on Plan FY 2007 Guidance Revised; Preliminary FY 2008 Guidance

AngioDynamics to Hold Fiscal 2007 Third Quarter Financial Results Conference Call on Tuesday, March 27, 2007 QUEENSBURY, N.Y.--(BUSINESS WIRE)--March 21, 2007--AngioDynamics, Inc. (NASDAQ:ANGO) today announced that the company will release fiscal 2007 third quarter results after the market closes

AngioDynamics Expands Vascular Access Port Portfolio with Introduction of the Smart Port(TM) CT AngioDynamics Expands Vascular Access Port Portfolio with Introduction of the Smart Port(TM) CT QUEENSBURY, N.Y.--(BUSINESS WIRE)--Feb. 28, 2007--AngioDynamics, Inc.

AngioDynamics to Present at Raymond James 28th Annual Institutional Investors Conference AngioDynamics to Present at Raymond James 28th Annual Institutional Investors Conference QUEENSBURY, N.Y.--(BUSINESS WIRE)--Feb. 27, 2007--AngioDynamics, Inc. (Nasdaq:ANGO) today announced that Joseph G.

AngioDynamics Completes RITA Medical Systems Acquisition QUEENSBURY, N.Y.--(BUSINESS WIRE)--Jan. 29, 2007--AngioDynamics, Inc. (Nasdaq:ANGO) announced today that it has completed the acquisition of RITA Medical Systems, Inc ("RITA"). As a result of the acquisition, each share of RITA common stock

AngioDynamics Completes RITA Medical Systems Acquisition QUEENSBURY, N.Y.--(BUSINESS WIRE)--Jan. 29, 2007--AngioDynamics, Inc. (Nasdaq:ANGO) announced today that it has completed the acquisition of RITA Medical Systems, Inc ("RITA"). As a result of the acquisition, each share of RITA common stock

AngioDynamics and RITA Medical Systems Announce Expiration of Hart-Scott-Rodino Waiting Period for RITA Medical Systems Acquisition QUEENSBURY, N.Y. & FREMONT, Calif.--(BUSINESS WIRE)--Jan. 12, 2007--AngioDynamics, Inc. (NASDAQ:ANGO) and RITA Medical Systems, Inc.

AngioDynamics and RITA Medical Systems Announce Expiration of Hart-Scott-Rodino Waiting Period for RITA Medical Systems Acquisition QUEENSBURY, N.Y. & FREMONT, Calif.--(BUSINESS WIRE)--Jan. 12, 2007--AngioDynamics, Inc. (NASDAQ:ANGO) and RITA Medical Systems, Inc.

AngioDynamics to Present at Needham 9th Annual Growth Stock Conference AngioDynamics to Present at Needham 9th Annual Growth Stock Conference QUEENSBURY, N.Y.--(BUSINESS WIRE)--Jan. 8, 2007--AngioDynamics, Inc. (Nasdaq:ANGO) today announced that Joseph G.

Raises full-year financial guidance; Conference call begins today at 4:30 p.m. Eastern time

AngioDynamics Sets Dates for Stockholders' Consideration of RITA Medical Systems Acquisition QUEENSBURY, N.Y.--(BUSINESS WIRE)--Dec. 22, 2006--AngioDynamics, Inc. (NASDAQ: ANGO) announced today that a special meeting of stockholders will be held on January 29, 2007, at which stockholders of record

AngioDynamics to Hold Fiscal 2007 Second Quarter Financial Results Conference Call on Wednesday, January 3, 2007 QUEENSBURY, N.Y.--(BUSINESS WIRE)--Dec. 13, 2006--AngioDynamics, Inc. (NASDAQ:ANGO) today announced that the company will release fiscal 2007 second quarter results after the market

AngioDynamics Announces Trial Date of March 12, 2007 in Diomed Patent Litigation QUEENSBURY, N.Y.--(BUSINESS WIRE)--Dec. 8, 2006--AngioDynamics, Inc. (Nasdaq:ANGO) today announced that U.S. District Judge Nathaniel M. Gorton has set March 12, 2007 as the start date for the jury trial in the Diomed

RITA Medical CEO to Present at the RBC Capital Markets 2006 Healthcare Conference FREMONT, Calif., Dec 07, 2006 /PRNewswire-FirstCall via COMTEX News Network/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a publicly-traded medical device company focused solely on cancer therapies, today announced

AngioDynamics to Present at RBC Capital Markets 2006 Healthcare Conference QUEENSBURY, N.Y.--(BUSINESS WIRE)--Dec. 6, 2006--AngioDynamics, Inc. (Nasdaq:ANGO) today announced that its president and chief executive officer, Eamonn P. Hobbs, will participate in a panel entitled: "Away From the Heart:

Newly Introduced Laparoscopic Surgical Device Designed to Reduce Blood Loss, Decrease Operating Times, Coagulate Highly Vascularized Tissue

Complementary Products and Shared Customer Bases Provide Clear Strategic Fit<br><br>

Expected to Result in Approximately $0.05 EPS Accretion in Fiscal Year 2008<br><br>

Conference Call Begins Today at 11:30 a.m. Eastern Time

AngioDynamics Announces FDA Clearance for Irreversible Electroporation Technology QUEENSBURY, N.Y.--(BUSINESS WIRE)--Nov. 27, 2006--AngioDynamics, Inc. (Nasdaq:ANGO) announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for Oncobionic, Inc.

AngioDynamics Comments on Markman Ruling in VNUS Litigation QUEENSBURY, N.Y.--(BUSINESS WIRE)--Nov. 21, 2006--AngioDynamics, Inc. (Nasdaq:ANGO) today announced that on November 20, 2006, United States District Court Judge Maxine Chesney issued a Markman ruling in the first stage of the patent